Xylem Inc. (XYL)
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-09-04
$105.69-2.04%
Close 2026-09-04 · 1-day change
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-09-04
Intact: The reason to own it still holds.
Xylem grows revenue about 4% yearly with steady profit margins near 23%. Free cash flow margin stays strong around 10%. The company buys back shares and beats earnings estimates consistently.
Revenue growth could stall below 3%. Profit margins might shrink due to cost pressures. Free cash flow margin could weaken if capital allocation falters.
The price is about 10% below our fair value near $135. Analysts expect roughly 4% revenue growth, which aligns with our view. Our fair value is 12% below the Street median, reflecting a more cautious outlook.
Breaks if: Fails to beat EPS or cuts guidance in FY26
Breaks if: Free cash flow margin falls below 9% in FY26
Breaks if: Gross margin falls below 22% in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on consistent revenue and margin growth. The current thesis state is stable, with management prioritizing key financial metrics and recent performance showing positive trends.
The market appears to have priced in a low fragility factor, reflecting a justified valuation compared to peers. There is a slight expectations gap, indicating that investors may not fully anticipate the potential for revenue and margin growth.
Management is on track with its priorities, as revenue and adjusted EBITDA margins have shown improvement. However, there is a mixed outlook on free cash flow margin, which could introduce some near-term risk.
The long-term thesis hinges on the performance of sector bellwethers and management's ability to maintain guidance. Any cuts to guidance or negative earnings from key peers could impact sentiment and performance.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The company reported a recent earnings beat, which supports the thesis. However, a CFO transition may disrupt financial strategy execution, posing a threat.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: YoY revenue growth falls below 3% in FY26
Overall, XYL's fundamentals are showing positive momentum, but external factors and management execution will be crucial in the coming months. Not investment advice.